Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
We were interested in elucidating the non-neurologic health of patients with autosomal recessive <i>SLC13A5</i> Citrate Transporter (NaCT) Disorder. Multiple variants have been reported that cause a loss of transporter activity, resulting in significant neurologic impairment, including s...
Enregistré dans:
| Auteurs principaux: | Tanya L. Brown, Kimberly L. Nye, Brenda E. Porter |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/295c0f16012f45c28b1cd63939c1d7cc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evidence for a Genotype–Phenotype Correlation in Patients with Pathogenic <i>GLUT2</i> (<i>SLC2A2</i>) Variants
par: Sarah C. Grünert, et autres
Publié: (2021) -
Diethyl citrate and sodium citrate reduce the cytotoxic effects of nanosized hydroxyapatite crystals on mouse vascular smooth muscle cells
par: Zhang CY, et autres
Publié: (2017) -
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
par: Kunnuru SKR, et autres
Publié: (2020) -
Renal Hypouricemia 1: Rare Disorder as Common Disease in Eastern Slovakia Roma Population
par: Blanka Stiburkova, et autres
Publié: (2021) -
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
par: Szymon Zmorzynski, et autres
Publié: (2021)